Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300534 · ClinicalTrials.gov registry record · NA
Multi-site Study of Rapid Diagnostic Syphilis Assays
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT00300534 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,000 participants.
The verdict
NCT00300534, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The performance of an investigational immunochromatographic strip (ICS) test for the diagnosis of syphilis is compared with the Abbott Laboratories Determine ICS test. The study population consists of patients with and without syphilis presenting to sexually transmitted disease clinics in five cities in the United States. Specimens include finger-stick whole blood (investigational test only) and whole blood, plasma, and serum by venipuncture.
Interventions
- DEVICE Abbott Laboratories Determine test for syphilis
- DEVICE Investigational syphilis immunochromatographic strip test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2002-08 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00300534
The ClinicalTrials.gov registry entry for NCT00300534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Abbott Laboratories Determine test for syphilis is the first listed.
NCT00300534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00300534 about?
NCT00300534 is a clinical study titled "Multi-site Study of Rapid Diagnostic Syphilis Assays". The performance of an investigational immunochromatographic strip (ICS) test for the diagnosis of syphilis is compared with the Abbott Laboratories Determine ICS test. The study population consists of patients with and without syphilis presenting to sexually transmitted disease clinics in five citie...
What is the current status of trial NCT00300534?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2002-08. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00300534?
The interventions under investigation include: Abbott Laboratories Determine test for syphilis (DEVICE), Investigational syphilis immunochromatographic strip test (DEVICE).
Who is sponsoring clinical trial NCT00300534?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.